David Hallal insider trades: iTeos Therapeutics (ITOS) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where David reports to the SEC
Open-market buys and sales
65 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 6, 2025 | ITOS | ↓ Sell | 114,682 | $10.15 | $1.2M | Direct | Jun 6, 2025 (0d) |
| Oct 19, 2022 | ALVR | ↓ Sell | 600,000 | $8.45 | $5.1M | Indirect | Oct 21, 2022 (2d) |
| Sep 29, 2022 | ALVR | ↓ Sell | 400,000 | $7.35 | $2.9M | Indirect | Sep 30, 2022 (1d) |
| Jul 21, 2022 | ALVR | ↓ Sell | 4,227 | $5.33 | $23K | Direct | Jul 21, 2022 (0d) |
| Jun 9, 2022 | ITOS | ↓ Sell | 29,615 | $20.17 | $597K | Direct | Jun 10, 2022 (1d) |
| Jun 3, 2022 | ALVR | ↓ Sell | 65,725 | $3.67 | $241K | Direct | Jun 6, 2022 (3d) |
| Apr 21, 2022 | ALVR | ↓ Sell | 4,227 | $5.87 | $25K | Direct | Apr 22, 2022 (1d) |
| Mar 11, 2022 | ALVR | ↓ Sell | 65,725 | $7.48 | $492K | Direct | Mar 11, 2022 (0d) |
| Jan 24, 2022 | ALVR | ↓ Sell | 17,100 | $8.01 | $137K | Direct | Jan 25, 2022 (1d) |
| Dec 20, 2021 | ITOS | ↓ Sell | 50,000 | $43.57 | $2.2M | Direct | Dec 22, 2021 (2d) |
| Aug 8, 2016 | ALXN | ↓ Sell | 332 | $137.14 | $46K | Direct | Aug 10, 2016 (2d) |
| Apr 1, 2016 | ALXN | ↓ Sell | 1,414 | $135.88 | $192K | Direct | Apr 5, 2016 (4d) |
| Feb 29, 2016 | ALXN | ↓ Sell | 2,014 | $138.93 | $280K | Direct | Mar 1, 2016 (1d) |
| Feb 8, 2016 | ALXN | ↓ Sell | 11,297 | $140.50 | $1.6M | Direct | Feb 8, 2016 (0d) |
| Aug 7, 2015 | ALXN | ↓ Sell | 329 | $190.01 | $63K | Direct | Aug 11, 2015 (4d) |
| Aug 4, 2015 | ALXN | ↓ Sell | 612 | $196.52 | $120K | Direct | Aug 5, 2015 (1d) |
| Mar 2, 2015 | ALXN | ↓ Sell | 730 | $180.34 | $132K | Direct | Mar 3, 2015 (1d) |
| Feb 10, 2015 | ALXN | ↓ Sell | 1,980 | $171.15 | $339K | Direct | Feb 12, 2015 (2d) |
| Feb 9, 2015 | ALXN | ↓ Sell | 2,920 | $173.93 | $508K | Direct | Feb 9, 2015 (0d) |
| Feb 4, 2015 | ALXN | ↓ Sell | 1,373 | $174.18 | $239K | Direct | Feb 5, 2015 (1d) |
| Dec 18, 2014 | ALXN | ↓ Sell10b5-1 | 5,494 | $182.03 | $1.0M | Family Trust | Dec 19, 2014 (1d) |
| Nov 3, 2014 | ALXN | ↓ Sell | 30,000 | $190.01 | $5.7M | Direct | Nov 4, 2014 (1d) |
| Aug 4, 2014 | ALXN | ↓ Sell | 1,349 | $158.00 | $213K | Direct | Aug 5, 2014 (1d) |
| Feb 7, 2014 | ALXN | ↓ Sell | 1,620 | $155.57 | $252K | Direct | Feb 10, 2014 (3d) |
| Feb 4, 2014 | ALXN | ↓ Sell | 3,119 | $154.45 | $482K | Direct | Feb 5, 2014 (1d) |
| Jan 29, 2014 | ALXN | ↓ Sell | 729 | $133.45 | $97K | Direct | Jan 31, 2014 (2d) |
| Dec 18, 2013 | ALXN | ↓ Sell10b5-1 | 15,363 | $127.61 | $2.0M | Family Trust | Dec 20, 2013 (2d) |
| Dec 18, 2013 | ALXN | ↓ Sell10b5-1 | 7,295 | $127.53 | $930K | Direct | Dec 20, 2013 (2d) |
| Dec 9, 2013 | ALXN | ↓ Sell10b5-1 | 14,637 | $127.63 | $1.9M | Family Trust | Dec 11, 2013 (2d) |
| Dec 9, 2013 | ALXN | ↓ Sell10b5-1 | 10,705 | $127.63 | $1.4M | Direct | Dec 11, 2013 (2d) |
| Oct 28, 2013 | ALXN | ↓ Sell10b5-1 | 30,000 | $123.05 | $3.7M | Family Trust | Oct 30, 2013 (2d) |
| Oct 28, 2013 | ALXN | ↓ Sell10b5-1 | 18,000 | $123.05 | $2.2M | Direct | Oct 30, 2013 (2d) |
| Aug 5, 2013 | ALXN | ↓ Sell | 730 | $116.87 | $85K | Direct | Aug 7, 2013 (2d) |
| Jul 30, 2013 | ALXN | ↓ Sell | 746 | $110.86 | $83K | Direct | Aug 1, 2013 (2d) |
| Jul 12, 2013 | ALXN | ↓ Sell10b5-1 | 50,000 | $120.00 | $6.0M | Direct | Jul 16, 2013 (4d) |
| Feb 4, 2013 | ALXN | ↓ Sell | 2,085 | $96.18 | $201K | Direct | Feb 6, 2013 (2d) |
| Jan 29, 2013 | ALXN | ↓ Sell | 1,144 | $94.42 | $108K | Direct | Jan 30, 2013 (1d) |
| Jul 31, 2012 | ALXN | ↓ Sell | 51,235 | $107.69 | $5.5M | Direct | Jul 31, 2012 (0d) |
| Jun 15, 2012 | ALXN | ↓ Sell | 14,308 | $93.67 | $1.3M | Direct | Jun 19, 2012 (4d) |
| Feb 23, 2012 | ALXN | ↓ Sell | 40,000 | $85.50 | $3.4M | Direct | Feb 24, 2012 (1d) |
| Jan 30, 2012 | ALXN | ↓ Sell | 2,450 | $74.49 | $182K | Direct | Jan 30, 2012 (0d) |
| Jan 10, 2012 | ALXN | ↓ Sell | 536 | $75.00 | $40K | Direct | Jan 11, 2012 (1d) |
| Nov 28, 2011 | ALXN | ↓ Sell | 20,000 | $66.59 | $1.3M | Direct | Nov 30, 2011 (2d) |
| Jul 28, 2011 | ALXN | ↓ Sell | 37,427 | $57.33 | $2.1M | Direct | Jul 28, 2011 (0d) |
| Jul 11, 2011 | ALXN | ↓ Sell | 501 | $50.00 | $25K | Direct | Jul 12, 2011 (1d) |
| Mar 3, 2011 | ALXN | ↓ Sell | 5,000 | $99.23 | $496K | Direct | Mar 4, 2011 (1d) |
| Jan 27, 2011 | ALXN | ↓ Sell | 1,110 | $84.70 | $94K | Direct | Jan 28, 2011 (1d) |
| Jan 18, 2011 | ALXN | ↓ Sell | 245 | $82.66 | $20K | Direct | Jan 18, 2011 (0d) |
| Jan 10, 2011 | ALXN | ↓ Sell | 269 | $81.27 | $22K | Direct | Jan 12, 2011 (2d) |
| Dec 15, 2010 | ALXN | ↓ Sell | 13,616 | $79.33 | $1.1M | Direct | Dec 29, 2010 (14d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About David Hallal's insider trades
David Hallal is an insider at iTeos Therapeutics (ITOS). Since Jun 11, 2009, David has reported no open-market purchases and 65 sales worth $61.9M on SEC Form 4. There have been no open-market trades in the last 12 months.
8 sales (31% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (41 filings), option exercises (26 filings), other transactions (7 filings), gifts (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ITOS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.